327 related articles for article (PubMed ID: 25387119)
1. Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease.
Meyer PM; Tiepolt S; Barthel H; Hesse S; Sabri O
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):376-86. PubMed ID: 25387119
[TBL] [Abstract][Full Text] [Related]
2. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
[TBL] [Abstract][Full Text] [Related]
3. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
[TBL] [Abstract][Full Text] [Related]
4. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
[TBL] [Abstract][Full Text] [Related]
5. (+)-[
Tiepolt S; Becker GA; Wilke S; Cecchin D; Rullmann M; Meyer PM; Barthel H; Hesse S; Patt M; Luthardt J; Wagenknecht G; Sattler B; Deuther-Conrad W; Ludwig FA; Fischer S; Gertz HJ; Smits R; Hoepping A; Steinbach J; Brust P; Sabri O
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):731-746. PubMed ID: 32935187
[TBL] [Abstract][Full Text] [Related]
6. Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.
Horti AG; Kuwabara H; Holt DP; Dannals RF; Wong DF
J Labelled Comp Radiopharm; 2013; 56(3-4):159-66. PubMed ID: 24285321
[TBL] [Abstract][Full Text] [Related]
7. Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.
Meyer PM; Strecker K; Kendziorra K; Becker G; Hesse S; Woelpl D; Hensel A; Patt M; Sorger D; Wegner F; Lobsien D; Barthel H; Brust P; Gertz HJ; Sabri O; Schwarz J
Arch Gen Psychiatry; 2009 Aug; 66(8):866-77. PubMed ID: 19652126
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
Matsuura Y; Ueda M; Higaki Y; Watanabe K; Habara S; Kamino S; Saji H; Enomoto S
Nucl Med Biol; 2016 Jun; 43(6):372-8. PubMed ID: 27260778
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease.
Lorenz R; Samnick S; Dillmann U; Schiller M; Ong MF; Faßbender K; Buck A; Spiegel J
Acta Neurol Scand; 2014 Sep; 130(3):164-71. PubMed ID: 24762290
[TBL] [Abstract][Full Text] [Related]
10. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
Wong DF; Kuwabara H; Kim J; Brasic JR; Chamroonrat W; Gao Y; Valentine H; Willis W; Mathur A; McCaul ME; Wand G; Gean EG; Dannals RF; Horti AG
J Nucl Med; 2013 Aug; 54(8):1308-14. PubMed ID: 23801676
[TBL] [Abstract][Full Text] [Related]
11. Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.
Hillmer AT; Esterlis I; Gallezot JD; Bois F; Zheng MQ; Nabulsi N; Lin SF; Papke RL; Huang Y; Sabri O; Carson RE; Cosgrove KP
Neuroimage; 2016 Nov; 141():71-80. PubMed ID: 27426839
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.
Pimlott SL; Piggott M; Owens J; Greally E; Court JA; Jaros E; Perry RH; Perry EK; Wyper D
Neuropsychopharmacology; 2004 Jan; 29(1):108-16. PubMed ID: 12955099
[TBL] [Abstract][Full Text] [Related]
13. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease.
Schmaljohann J; Gündisch D; Minnerop M; Bucerius J; Joe A; Reinhardt M; Guhlke S; Biersack HJ; Wüllner U
Nucl Med Biol; 2006 Apr; 33(3):305-9. PubMed ID: 16631078
[TBL] [Abstract][Full Text] [Related]
15. 123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment.
Mitsis EM; Reech KM; Bois F; Tamagnan GD; Macavoy MG; Seibyl JP; Staley JK; van Dyck CH
J Nucl Med; 2009 Sep; 50(9):1455-63. PubMed ID: 19690024
[TBL] [Abstract][Full Text] [Related]
16. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
[TBL] [Abstract][Full Text] [Related]
17. Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.
Ellis JR; Villemagne VL; Nathan PJ; Mulligan RS; Gong SJ; Chan JG; Sachinidis J; O'Keefe GJ; Pathmaraj K; Wesnes KA; Savage G; Rowe CC
Neurobiol Learn Mem; 2008 Sep; 90(2):404-12. PubMed ID: 18620875
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine receptors in dementia and mild cognitive impairment.
Sabri O; Kendziorra K; Wolf H; Gertz HJ; Brust P
Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S30-45. PubMed ID: 18228017
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
[TBL] [Abstract][Full Text] [Related]
20. Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
Kendziorra K; Wolf H; Meyer PM; Barthel H; Hesse S; Becker GA; Luthardt J; Schildan A; Patt M; Sorger D; Seese A; Gertz HJ; Sabri O
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):515-25. PubMed ID: 21069319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
